Weight loss surgery has long been an effective treatment for the more than 40 percent of American adults struggling with obesity.

Colorectal cancer highlights from ASCO 2025 include findings from the BREAKWATER, ATOMIC, DYNAMIC-III, and TRIPLETE trials.

The UNC Lineberger Comprehensive Cancer Center has been awarded $28 million for a new clinical breast cancer trial.

Chemotherapy seeks to destroy tumor cells and has been a standard treatment for cancer for decades. However, it doesn't ...

"Science saved my life, and I want to use it to help others," writes Claire Brown about proposed federal funding cuts.

Research presented at the ASCO Annual Meeting 2025 highlighted new potential standards of care and other advances in breast cancer.

Colorectal cancer (CRC) is the second most common cause of death from cancer in the US and the most prevalent malignant tumor ...

A new technique lets researchers make many more of the particles much faster, using consistent practices that meet safety ...

Once the biomarkers were developed, the CNIO team tested them in an innovative way: with a simulated trial, that is, with ...

In 2023, the oncology market was valued at approximately $150 billion, yet, over 70% of this market is dominated by treatments for common cancers such as lung and breast cancer.

OCCAM Immune, a Mount Sinai research organization, will sequence and map cells from samples collected in CRI's immunotherapy trials.